Search

Gilda Beverly Loew

Deceased

from Stockton, CA

Also known as:
  • Gilda B Loew
  • Gilda Beverly Looe

Gilda Loew Phones & Addresses

  • Stockton, CA
  • Palo Alto, CA
  • Tahoe City, CA
  • San Francisco, CA
  • 255 Polhemus Ave, Atherton, CA 94027
  • Port Jefferson Station, NY
  • Encino, CA

Us Patents

  • N-Acylated Lipophilic Amino Acid Derivatives

    view source
  • US Patent:
    6864250, Mar 8, 2005
  • Filed:
    Aug 20, 1998
  • Appl. No.:
    09/485845
  • Inventors:
    Hidenori Funamizu - Kyoto, JP
    Nobuo Ishiyama - Kyoto, JP
    Satoru Ikegami - Kyoto, JP
    Tadashi Okuno - Kyoto, JP
    Kiyoshi Inoguchi - Kyoto, JP
    Ping Huang - Mountain View CA, US
    Gilda Loew - Mountain View CA, US
  • Assignee:
    Kaken Pharmaceutical Co., Ltd. - Tokyo
    Molecular Research Institute - Mountain View CA
  • International Classification:
    A61K031/55
    A61P019/00
    C07D267/02
    C07D281/02
  • US Classification:
    51421104, 51421107, 540488, 540491
  • Abstract:
    Compounds of structural Formula (I) where A is a lipophilic group including an aliphatic bridging group, B is a lipophilic group, D is a group having at least one amino or substituted amino group and R is hydrogen, alkyl or cycloalkyl, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals.
  • N-Acylated Lipophilic Amino Acid Derivatives

    view source
  • US Patent:
    7064121, Jun 20, 2006
  • Filed:
    Oct 13, 2004
  • Appl. No.:
    10/962598
  • Inventors:
    Hidenori Funamizu - Kyoto, JP
    Nobuo Ishiyama - Kyoto, JP
    Satoru Ikegami - Kyoto, JP
    Tadashi Okuno - Kyoto, JP
    Kiyoshi Inoguchi - Kyoto, JP
    Ping Huang - Mountain View CA, US
    Gilda Loew - Mountain View CA, US
  • Assignee:
    Kaken Pharmaceutical Co., Ltd. - Tokyo
    Molecular Research Institute - Mountain View CA
  • International Classification:
    A61P 19/00
    A61K 31/55
    C07D 267/14
    C07D 267/16
    C07D 281/10
  • US Classification:
    514220, 514221, 540496, 540506
  • Abstract:
    Compounds of structural Formula (I) where A is a lipophilic group including an aliphatic bridging group, B is a lipophilic group, D is a group having at least one amino or substituted amino group and R is hydrogen, alkyl or cycloalkyl, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals.
  • Amide Derivatives

    view source
  • US Patent:
    7279573, Oct 9, 2007
  • Filed:
    Feb 23, 2006
  • Appl. No.:
    11/359616
  • Inventors:
    Hidenori Funamizu - Kyoto, JP
    Nobuo Ishiyama - Kyoto, JP
    Satoru Ikegami - Kyoto, JP
    Tadashi Okuno - Kyoto, JP
    Kiyoshi Inoguchi - Kyoto, JP
    Ping Huang - Mountain View CA, US
    Gilda Loew - Mountain View CA, US
  • Assignee:
    Kaken Pharmaceutical Co., Ltd. - Tokyo
    Molecular Research Institute - Mountain View CA
  • International Classification:
    A61P 5/00
    A61K 31/55
    C07D 267/00
  • US Classification:
    540523, 540461, 540522
  • Abstract:
    Compounds of structural Formula (I) where A is a lipophilic group including an aliphatic bridging group, B is a lipophilic group, D is a group having at least one amino or substituted amino group and R is hydrogen, alkyl or cycloalkyl, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals.
  • Novel Amide Derivatives As Growth Hormone Secretagogues

    view source
  • US Patent:
    20060014701, Jan 19, 2006
  • Filed:
    Sep 6, 2005
  • Appl. No.:
    11/218562
  • Inventors:
    Nobuo Ishiyama - Kyoto, JP
    Hirohide Ishige - Kyoto, JP
    Mitsuo Mimura - Kyoto, JP
    Tadashi Okuno - Kyoto, JP
    Kiyoharu Ukai - Kyoto, JP
    Takeshi Kiyofuji - Kyoto, JP
    Shinji Tauchi - Shizuoka, JP
    Kiyoshi Inoguchi - Kyoto, JP
    Ping Huang - Mountain View CA, US
    Gilda Loew - Mountain View CA, US
    Linda Maki - Menlo Park CA, US
  • Assignee:
    Kaken Pharmaceutical Co., Ltd. - Tokyo
    Molecular Research Institute - Mountain View CA
  • International Classification:
    A61K 38/04
    C07K 5/04
  • US Classification:
    514019000, 548537000, 564152000
  • Abstract:
    Disclosed are the novel compounds as growth hormone secretagogues represented by the structural Formula I: wherein Ris, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted aryl, or substituted or unsubstituted amino, X is —CO— or —SO—, Y is: wherein n is an integer from 0-4, Ris hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, Rand Rare independently selected from hydrogen, substituted or unsubstituted alkyl, or Rand Ror Rand Rare taken together to form substituted or unsubstituted alkylene, Ris hydrogen, or substituted or unsubstituted alkyl, Ris substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, D is substituted or unsubstituted amino, substituted or unsubstituted alkoxy, or substituted or unsubstituted alkylthio, * represents an asymmetric center, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals.
  • N-Acylated Lipophilic Amino Acid Derivatives

    view source
  • US Patent:
    20080027038, Jan 31, 2008
  • Filed:
    Aug 20, 2007
  • Appl. No.:
    11/892063
  • Inventors:
    HIdenori Funamizu - Kyoto-shi, JP
    Nobuo Ishiyama - Kyoto-shi, JP
    Satoru Ikegami - Kyoto-shi, JP
    Tadashi Okumo - Kyoto-shi, JP
    Kiyoshi Inoguchi - Kyoto-shi, JP
    Ping Huang - Mountain View CA, US
    Gilda Loew - Mountain View CA, US
  • Assignee:
    Kaken Pharmaceutical Co., Ltd. - Tokyo
    Molecular Research Institute - Palo Alto CA
  • International Classification:
    A61K 31/55
    A61K 31/5513
    A61K 31/553
    A61K 31/554
    A61P 17/02
    A61P 19/10
    A61P 5/00
    C07D 243/10
    C07D 267/14
    C07D 281/10
    C07D 403/12
    C07D 417/12
  • US Classification:
    514211070, 514212070, 514220000, 540491000, 540504000, 540523000
  • Abstract:
    Compounds of structural formula (I) where A is a lipophilic group including an aliphatic bridging group, B is a lipophilic group, D is a group having at least one amino or substituted amino group and R is hydrogen, alkyl or cycloalkyl, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals.
  • N-.Alpha.methylcyclopropylmethyl Derivatives Of Normorphine And Noroodeine, And Analgesic Compositions And Methods Employing The Normorphine Derivatives

    view source
  • US Patent:
    42184541, Aug 19, 1980
  • Filed:
    May 24, 1978
  • Appl. No.:
    5/909257
  • Inventors:
    Joseph I. DeGraw - Sunnyvale CA
    John A. Lawson - Monte Vista CA
    Howard L. Johnson - Sunnyvale CA
    Gilda H. Loew - Atherton CA
    Donald A. Berkowitz - El Cerrito
  • Assignee:
    SRI International - Menlo Park CA
  • International Classification:
    A61K 31485
    C07D48902
  • US Classification:
    424260
  • Abstract:
    Novel N-sec-alkyl derivatives of norcodeine and normorphine wherein the sec-alkyl group contains either four or five carbon atoms. Specifically included are those derivatives of norcodeine and normorphine wherein the sec-alkyl group is 2-butyl, 3-pentyl,. alpha. -methylallyl and. alpha. -methylcyclopropylmethyl. The normorphine derivatives have strong agonist potency combined with strong antagonist qualities and indicated low addiction potential. The norcodeine analogs are useful as intermediates in preparing the corresponding normorphine compounds.
  • Orally Active Nonaddicting Analgesics

    view source
  • US Patent:
    47497068, Jun 7, 1988
  • Filed:
    Mar 24, 1986
  • Appl. No.:
    6/843150
  • Inventors:
    John A. Lawson - Fremont CA
    Joseph I. DeGraw - Sunnyvale CA
    Gilda H. Loew - Atherton CA
  • Assignee:
    SRI International - Menlo Park CA
  • International Classification:
    A61K 31485
    C07D48902
  • US Classification:
    514282
  • Abstract:
    Stereoisomerically pure forms of normorphine analogs which have superior analgesic and nonaddicting qualities are described. In addition, a method of separating diastereomeric forms of N-sec-alkyl-substituted analogs utilizes the hydrocarbyl(1-8C) diesters of the normorphine derivatives. A new method for preparing the N-methylalkylmethyl derivatives of normorphine and norcodeine and their conventional analogs is also disclosed. This method employs the corresponding methyl alkyl ketones and a reducing agent.
  • N-Sec-Alkyl Analogs Of Norcodeine And Normorphine And Analgesic Compositions And Methods Employing The Normorphine Derivatives

    view source
  • US Patent:
    42698430, May 26, 1981
  • Filed:
    Jul 8, 1980
  • Appl. No.:
    6/166948
  • Inventors:
    Joseph I. De Graw - Sunnyvale CA
    John A. Lawson - Monte Vista CA
    Howard L. Johnson - Sunnyvale CA
    Gilda H. Loew - Atherton CA
  • Assignee:
    SRI International - Menlo Park CA
    The Board of Trustees of Leland Stanford Jr. University - Stanford CA
  • International Classification:
    A61K 31485
    C07D48902
  • US Classification:
    424260
  • Abstract:
    Novel N-sec-alkyl derivatives of norcodeine and normorphine wherein the sec-alkyl group contains either four or five carbon atoms. Specifically included are those derivatives of norcodeine and normorphine wherein the sec-alkyl group is 2-butyl, 3-pentyl,. alpha. -methylallyl and. alpha. -methylcyclopropylmethyl. The normorphine derivatives having strong agonist potency combined with strong antagonist qualities and indicated low addiction potential. The norcodeine analogs are useful as intermediates in preparing the corresponding normorphine compounds.

Get Report for Gilda Beverly Loew from Stockton, CADeceased
Control profile